TG Therapeutics Inc

TG Therapeutics Inc

TGTX

Market Cap$4.78B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
TG Therapeutics IncTG Therapeutics Inc-310.2--7%31.20.1
$55.00

Target Price by Analysts

76.5% upsideTG Therapeutics Target Price DetailsTarget Price
$16.18

Current Fair Value

48.1% downside

Overvalued by 48.1% based on the discounted cash flow analysis.

Share Statistics

Market cap$4.78 Billion
Enterprise Value$4.60 Billion
Dividend Yield$0 (0%)
Earnings per Share$0.09
Beta2.19
Outstanding Shares145,102,479

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio-310.23
PEG321.16
Price to Sales31.16
Price to Book Ratio31.16
Enterprise Value to Revenue17.39
Enterprise Value to EBIT-9115.63
Enterprise Value to Net Income-321
Total Debt to Enterprise0
Debt to Equity0.1

Revenue Sources

No data

Insider Trades

ESG Score

No data

About TG Therapeutics Inc

CEO: Michael Weiss